Michèl R. Klein

7.5k total citations · 2 hit papers
73 papers, 5.6k citations indexed

About

Michèl R. Klein is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Michèl R. Klein has authored 73 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 37 papers in Immunology and 28 papers in Virology. Recurrent topics in Michèl R. Klein's work include HIV Research and Treatment (28 papers), Tuberculosis Research and Epidemiology (25 papers) and Immune Cell Function and Interaction (25 papers). Michèl R. Klein is often cited by papers focused on HIV Research and Treatment (28 papers), Tuberculosis Research and Epidemiology (25 papers) and Immune Cell Function and Interaction (25 papers). Michèl R. Klein collaborates with scholars based in Netherlands, United States and United Kingdom. Michèl R. Klein's co-authors include Frank Miedema, Dörte Hamann, René A. W. van Lier, Paul A. Baars, M.H.G. Rep, Berend Hooibrink, Tom H. M. Ottenhoff, Ireneus P.M. Keet, Krista E. van Meijgaarden and Kees L. M. C. Franken and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Michèl R. Klein

72 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells

1997 1.1k citations Michèl R. Klein et al. The Journal of Experimental Medicine profile →
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

1995 548 citations Michèl R. Klein, Carel A. van Baalen et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Michèl R. Klein

Since Specialization

Citations

This map shows the geographic impact of Michèl R. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèl R. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèl R. Klein more than expected).

Fields of papers citing papers by Michèl R. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèl R. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèl R. Klein. The network helps show where Michèl R. Klein may publish in the future.

Co-authorship network of co-authors of Michèl R. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Michèl R. Klein. A scholar is included among the top collaborators of Michèl R. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèl R. Klein. Michèl R. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area 2012 ·PLoS ONE ·Novel N. Chegou, Paulin N. Essone, André G. Loxton, Kim Stanley, Gillian F. Black, Gian van der Spuy, Paul D. van Helden, Kees L. M. C. Franken, Shreemanta K. Parida, Michèl R. Klein, Stefan H. E. Kaufmann, Tom H. M. Ottenhoff, Gerhard Walzl	49
2	Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers 2010 ·Vaccine ·Jaap T. van Dissel, Sandra M. Arend, Corine Prins, Peter Fibiger Bang, Pernille N. Tingskov, Karen Lingnau, Jan Nouta, Michèl R. Klein, Ida Rosenkrands, Tom H. M. Ottenhoff, Ingrid Kromann, T. Mark Doherty, Peter Andersen	166
3	Genome-Based In Silico Identification of New Mycobacterium tuberculosis Antigens Activating Polyfunctional CD8+ T Cells in Human Tuberculosis 2010 ·The Journal of Immunology ·Sheila Tuyet Tang, Krista E. van Meijgaarden, Nadia Caccamo, Giuliana Guggino, Michèl R. Klein, (unknown), (unknown), Anette Stryhn, (unknown), Uğur Şahin, Søren Buus, Francesco Dieli, Ole Lund, Tom H. M. Ottenhoff	42
4	Identification of a human CD8 ⁺ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4 2007 ·Proceedings of the National Academy of Sciences ·Simone A. Joosten, Krista E. van Meijgaarden, Nigel D. L. Savage, Tjitske de Boer, Frédéric Triebel, Annemieke van der Wal, Emile de Heer, Michèl R. Klein, Annemieke Geluk, Tom H. M. Ottenhoff	157
5	Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis 2006 ·Microbes and Infection ·Eliane M.S. Leyten, May Young Lin, Kees L. M. C. Franken, Annemieke H. Friggen, Corine Prins, Krista E. van Meijgaarden, Martin I. Voskuil, Karin Weldingh, Peter Andersen, Gary K. Schoolnik, Sandra M. Arend, Tom H. M. Ottenhoff, Michèl R. Klein	221
6	Leprosy bacillus triggers the wrong cells. 2005 ·PubMed ·Tom H. M. Ottenhoff, Michèl R. Klein	2
7	Monokine induced by interferon gamma and IFN-γ response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients 2005 ·Microbes and Infection ·Clarice Abramo, Krista E. van Meijgaarden, (unknown), Kees L. M. C. Franken, Michèl R. Klein, (unknown), Sérgio C. Oliveira, Tom H. M. Ottenhoff, Henrique Couto Teixeira	43
8	HLA‐B35–Restricted CD8 T Cell Epitopes in the Antigen 85 Complex ofMycobacterium tuberculosis 2001 ·The Journal of Infectious Diseases* ·Michèl R. Klein, (unknown), Abdulrahman S. Hammond, Graham S. Ogg, Abigail King, Johan Vekemans, Assan Jaye, Pauline T. Lukey, Keith P. W. J. McAdam	28
9	Consistent Associations of HLA Class I and II and Transporter Gene Products with Progression of Human Immunodeficiency Virus Type 1 Infection in Homosexual Men 1999 ·The Journal of Infectious Diseases ·Ireneus P.M. Keet, James Tang, Michèl R. Klein, (unknown), Cheryl Enger, Charles Rivers, Raymond Apple, Dean L. Mann, (unknown), Frank Miedema, Richard A. Kaslow	71
10	Functional T Cell Reconstitution and Human Immunodeficiency Virus–1–Specific Cell‐Mediated Immunity during Highly Active Antiretroviral Therapy 1999 ·The Journal of Infectious Diseases ·Oscar Pontesilli, (unknown), Daan W. Notermans, Norbert A. Foudraine, Marijke Roos, Michèl R. Klein, Sven A. Danner, Joep M. A. Lange, Frank Miedema	103
11	Longitudinal Analysis of Human Immunodeficiency Virus Type 1‐Specific Cytotoxic T Lymphocyte Responses: A Predominant Gag‐Specific Response Is Associated with Nonprogressive Infection 1998 ·The Journal of Infectious Diseases ·Oscar Pontesilli, Michèl R. Klein, (unknown), Nadine G. Pakker, (unknown), Hanneke Schuitemaker, Frank Miedema	84
12	Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. 1998 ·Journal of General Virology ·Michèl R. Klein, C J Melief, (unknown), Frank Miedema, Sjoerd H. van der Burg, Jan W. Drijfhout, Egbert Hovenkamp	82
13	Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. 1997 ·Journal of General Virology ·Carel A. van Baalen, R. C. Huisman, Michèl R. Klein, Rob A. Gruters, Frank Miedema, Anna María Geretti, Albert D. M. E. Osterhaus, Oscar Pontesilli, F de Wolf	162
14	Gag-Specific Immune Responses after Immunization with pl7/p24:Ty Virus-Like Particles in HIV Type 1-Seropositive Individuals 1997 ·AIDS Research and Human Retroviruses ·Michèl R. Klein, Jan A. Veenstra, (unknown), (unknown), (unknown), Gary Patou, R A Coutinho, Frank de Wolf, Frank Miedema	19
15	HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS 1997 ·The Journal of Immunology ·Sjoerd H. van der Burg, Michèl R. Klein, Oscar Pontesilli, (unknown), Jan W. Drijfhout, W. Martin Kast, Frank Miedema, C.J.M. Melief	22
16	Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. 1997 ·Journal of Clinical Investigation ·Marie José Kersten, Michèl R. Klein, (unknown), Frank Miedema, M. H. van Oers	67
17	Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1 1996 ·Journal of General Virology ·Carel A. van Baalen, Michèl R. Klein, R. C. Huisman, (unknown), (unknown), Anna María Geretti, Rob A. Gruters, Cécile A. C. M. van, Frank Miedema, Albert D. M. E. Osterhaus	21
18	Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. breakdown → 1995 ·The Journal of Experimental Medicine ·Michèl R. Klein, Carel A. van Baalen, (unknown), (unknown), Richard J. Bende, Ireneus P.M. Keet, (unknown), Albert D. M. E. Osterhaus, Hanneke Schuitemaker, Frank Miedema	548
19	Long-term survivors of HIV-1 infection 1995 ·Trends in Microbiology ·Michèl R. Klein, Frank Miedema	52
20	Finsim - A Decision Support System for Financial Planning and Engineering. 1977 ·IFIP Congress ·Michèl R. Klein	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact